BioSpace News Archive

Capital BlueCross chief medical officer and senior vice president of clinical solutions, Dr. Jennifer Chambers, today provided a keynote address at the Magellan Health - Leading Humanity to Healthy, Vibrant Lives conference in Lancaster

Midwest-based Cresco Labs, one of the fastest-growing cannabis companies in the United States, is attracting top-tier talent from mainstream industries, as it invests in executive-level hires that will further propel its already rapid growth and expansion.

NuVasive, Inc., (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will present at the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt New York in New York City on Wednesday, September 12, 2018, at 2:15 p.m. ET/11:15 a.m. PT.

Seismic, an apparel company creating clothes that improve quality of life through quality of motion, today unveiled its Spring 2019 Collection on stage at TechCrunch Disrupt, which is the world’s largest technology startup conference.

Today at GRx + Biosims: Engineering the Future of Generic + Biosimilar Medicines, the Association for Accessible Medicines’ (AAM) annual industry conference, a panel that examined prescription medicine access for patients who are uninsured, underinsured or affected by disasters was led by Amalia Adler-Waxman, VP, Social Impact & Responsibility, Teva Pharmaceuticals

SAGE Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will present at the Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday, September 12, 2018 at 01:40 P.M. ET in New York, NY.

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 16th Annual Global Healthcare Conference in New York, NY on Friday, September 14 at 11:40 a.m. Eastern Time.

Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, announced today that its Board of Directors has declared a $0.48 cash dividend to its stockholders.

Acquisition expands portfolio of men’s health in-office procedures with adjunctive therapy for prostate cancer patients